• AAPL 165.84
  • TSLA 142.05
  • AMZN 177.23
  • MSFT 400.96
  • INTC 34.41
  • EURUSD 1.0651
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. HKMPF.PINK

Hikma Pharmaceuticals PLC (HKMPF PINK) stock market data APIs

$22.33 0(0%) as of April 22, 2024

Hikma Pharmaceuticals PLC Financial Data Overview

22.33
22.33
-
22.33
22.33
21.284-27
4 955 M
26.2706
222 M
2 875 M
0.5345
0.0321
0.445
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'HKMPF',
Type: 'Common Stock',
Name: 'Hikma Pharmaceuticals PLC',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

Hikma Pharmaceuticals PLC Fundamental Data is available in our Financial Data APIs

  • Net Revenue 2 875 M
  • EBITDA 791 M
  • Earnings Per Share 0.85
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Hikma Pharmaceuticals PLC Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Hikma Pharmaceuticals PLC End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Hikma Pharmaceuticals PLC latest news via APIs

With 52% institutional ownership, Hikma Pharmaceuticals PLC (LON:HIK) is a favorite amongst the big guns

Key Insights Significantly high institutional ownership implies Hikma Pharmaceuticals' stock price is sensitive to their trading actions The top 14 shareholders own 51% of the company Using data from...

Optimism around Hikma Pharmaceuticals (LON:HIK) delivering new earnings growth may be shrinking as stock declines 3.3% this past week

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall ...
Do you have any questions?
support@eodhistoricaldata.com